Whitebeard Inc. logo

Whitebeard Inc. (WHIB)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
174.02K Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track WHIB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

WHIB closed Monday higher at $0, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, WHIB stock gained 0%.
WHIB is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

WHIB Chart

Whitebeard Inc. (WHIB) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Whitebeard Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is WHIB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 174.02K.

Has Whitebeard Inc. ever had a stock split?

No, there has never been a stock split.

Whitebeard Inc. Profile

Trading Companies & Distributors Industry
Industrials Sector
G. T. Cooper CEO
OTC PINK Exchange
- ISIN
GB Country
7 Employees
- Last Dividend
25 Jul 2025 Last Split
- IPO Date

Overview

In Veritas Medical Diagnostics, Inc., represents a development stage company deeply entrenched in the advancement of medical technologies aimed at enhancing near-patient testing applications. Originating as In Vivo Medical Diagnostics, Inc., the company underwent a rebranding in 2005 to better reflect its broadened vision and mission in the medical diagnostics arena. Its foundation lies in the United Kingdom, specifically in Inverness, where it continues to push the boundaries of medical diagnostic capabilities with a focus on creating innovative solutions that cater to a wide range of patient needs and medical conditions.

Products and Services

The company's diverse pipeline of products under development demonstrates its commitment to leveraging cutting-edge technology to improve patient care and outcomes. Among its offerings, the following stand out:

  • Prothrombin Monitor: This pivotal device is designed for the accurate measurement of blood coagulation in patients who are at an increased risk of heart disease and stroke. By providing timely and precise readings, the prothrombin monitor is an essential tool for monitoring and managing patients' coagulation levels, thereby helping to prevent potentially life-threatening complications.
  • Predictor of Labor Onset: A revolutionary consumer device aimed at maternity planning, this product is devised to predict the onset of labor, thus offering expecting mothers invaluable insight into their labor timelines. Such a device empowers women with the knowledge they need to better prepare for childbirth.
  • Biomarker Monitor: This innovation is under development to facilitate the measurement of various biomarkers, including those indicative of heart attack, HIV, cholesterol levels, and cancer. By enabling early detection and continuous monitoring, the biomarker monitor holds the potential to drastically improve patient management and outcomes across multiple disease states.
  • Blood Glucose Monitor: Aimed at revolutionizing diabetes management, this noninvasive device is being developed to continuously measure blood glucose levels without the need for frequent blood samples. Such a device promises to offer a more comfortable and convenient way for patients to manage their diabetes.
  • Digital Scanning Machine: This product represents a noninvasive alternative to traditional 2D X-ray scanning. By utilizing advanced digital scanning technology, this machine aims to provide safer, more comfortable imaging solutions for patients while maintaining high diagnostic accuracy.
  • Osteoporosis Detection and Monitoring Device: This device is tailored for instant display of bone mineral density, offering a quick and efficient tool for the detection and monitoring of osteoporosis. With the ability to provide immediate results, it enhances patient care by facilitating early intervention and ongoing management of this widespread condition.
  • Hand Held Digital Strip Reader for Immunoassay Applications: Tailored for the rapid and accurate reading of immunoassay tests, this handheld device simplifies the detection and quantification of various biological markers. Its portability and ease of use make it a valuable tool in a range of healthcare settings, from clinical laboratories to point-of-care environments.

Contact Information

Address: The Green House
Phone: 44 14 6366 7347